(Reuters) - Genetic testing firm 23andMe said on Monday it is reducing its overall headcount by over 200 employees or about 40% of the workforce, as part of a restructuring program.
The company expects annualized cost savings of more than $35 million as a result of the restructuring.
Source: Investing.com